Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in VIR BIOTECHNOLOGY INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 130,503 shares of VIR (VIR BIOTECHNOLOGY INC), worth $1.2M as of 2026-Q1. The position was increased (+7.8% shares). VIR represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$1.2M
Current Shares
130,503
Total Value Change
-$348,669
Total Shares Change
-40,056
Other major holders of VIR: CAPITAL FUND MANAGEMENT S.A.
Increased |
| 130,503 |
+7.8% |
| $1.2M |
| 0.0% |
| $8.91 |
27 |
| 2025-Q4 | Decreased | 121,080 | -15.9% | $730,113 | 0.0% | $5.84 | 0 |
| 2025-Q3 | Decreased | 143,938 | -51.1% | $821,886 | 0.0% | $5.63 | 0 |
| 2025-Q2 | Increased | 294,383 | +47.9% | $1.5M | 0.0% | $5.17 | 35 |
| 2025-Q1 | Increased | 199,063 | +9.8% | $1.3M | 0.0% | $6.70 | 28 |
| 2024-Q4 | Increased | 181,325 | +29.2% | $1.3M | 0.0% | $7.33 | 32 |
| 2024-Q3 | Decreased | 140,371 | -17.7% | $1.1M | 0.0% | $7.53 | 0 |
| 2024-Q2 | Increased | 170,559 | +85.3% | $1.5M | 0.0% | $8.90 | 40 |